Showing results (61-70 of 225) with videos related to

Sort By:
Pageof 23
Molecular Neurobiology|February 21, 2018
Towards a TDP-43-Based Biomarker for ALS and FTLDEmily Feneberg, Elizabeth Gray, Olaf Ansorge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 27, 2023
Aberrant dynein function promotes TDP-43 aggregation and upregulation of p62 in male mice harboring transgenic human TDP-43Eleni Christoforidou, Fabio A Simoes, David Gordon, et al.
The Lancet. Neurology|December 17, 2008
Biomarkers in amyotrophic lateral sclerosisMartin R Turner, Matthew C Kiernan, P Nigel Leigh, et al.
Brain Communications|October 9, 2025
Reduced beta bursting underpins loss of corticomuscular coherence in amyotrophic lateral sclerosisKatie Yoganathan, Michael Trubshaw, Oliver Kohl, et al.
Clinical Proteomics|January 17, 2026
Tetraspanin-based immunocapture for high-depth proteomic profiling of extracellular vesicles from cerebrospinal fluid for biomarker discoveryElizabeth R Dellar, Iolanda Vendrell, Roman Fischer, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 12, 2016
The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onsetMalcolm Proudfoot, Ashley Jones, Kevin Talbot, et al.
Neurology|August 16, 2013
Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic studyMartin R Turner, Raph Goldacre, Sreeram Ramagopalan, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 26, 2011
Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosisMatthew C Evans, Michel Modo, Kevin Talbot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 5, 2023
Premorbid brain structure influences risk of amyotrophic lateral sclerosisAlexander G Thompson, Bernd Taschler, Stephen M Smith, et al.
Pageof 23